These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38037475)

  • 21. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease.
    Kim D; Chung GE; Kwak MS; Kim YJ; Yoon JH
    Dig Liver Dis; 2018 Apr; 50(4):389-395. PubMed ID: 29373238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.
    Saponaro C; Sabatini S; Gaggini M; Carli F; Rosso C; Positano V; Armandi A; Caviglia GP; Faletti R; Bugianesi E; Gastaldelli A
    Liver Int; 2022 Nov; 42(11):2418-2427. PubMed ID: 35900229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease.
    Simon TG; Van Der Sloot KWJ; Chin SB; Joshi AD; Lochhead P; Ananthakrishnan AN; Xavier R; Chung RT; Khalili H
    Inflamm Bowel Dis; 2018 Sep; 24(10):2247-2257. PubMed ID: 29788077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Yu SJ; Kim W; Kim D; Yoon JH; Lee K; Kim JH; Cho EJ; Lee JH; Kim HY; Kim YJ; Kim CY
    Medicine (Baltimore); 2015 Dec; 94(48):e2159. PubMed ID: 26632897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy.
    Franchitto A; Carpino G; Alisi A; De Peppo F; Overi D; De Stefanis C; Romito I; De Vito R; Caccamo R; Sonia B; Alessandra S; Mosca A; Alterio A; Onori P; Gaudio E; Nobili V
    J Pediatr; 2020 Jan; 216():117-127.e2. PubMed ID: 31526528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD.
    Navaneethan SD; Kirwan JP; Remer EM; Schneider E; Addeman B; Arrigain S; Horwitz E; Fink JC; Lash JP; McKenzie CA; Rahman M; Rao PS; Schold JD; Shafi T; Taliercio JJ; Townsend RR; Feldman HI;
    Am J Kidney Dis; 2021 Jan; 77(1):44-55. PubMed ID: 32798563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrahepatic fat, abdominal adipose tissues, and metabolic state: magnetic resonance imaging study.
    Yaskolka Meir A; Tene L; Cohen N; Shelef I; Schwarzfuchs D; Gepner Y; Zelicha H; Rein M; Bril N; Serfaty D; Kenigsbuch S; Chassidim Y; Sarusy B; Dicker D; Thiery J; Ceglarek U; Stumvoll M; Blüher M; Stampfer MJ; Rudich A; Shai I
    Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28198147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth.
    Silveira LS; Monteiro PA; Antunes Bde M; Seraphim PM; Fernandes RA; Christofaro DG; Freitas Júnior IF
    BMC Pediatr; 2013 Aug; 13():115. PubMed ID: 23919592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.
    Lu Z; Pan X; Hu Y; Hao Y; Luo Y; Hu X; Ma X; Bao Y; Jia W
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):139-45. PubMed ID: 25363574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial.
    Guo W; Tian W; Lin L; Xu X
    Diabetes Res Clin Pract; 2020 Dec; 170():108487. PubMed ID: 33035599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study.
    Bidulescu A; Liu J; Hickson DA; Hairston KG; Fox ER; Arnett DK; Sumner AE; Taylor HA; Gibbons GH
    BMC Cardiovasc Disord; 2013 Feb; 13():9. PubMed ID: 23433085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease.
    Zubáňová V; Červinková Z; Kučera O; Palička V
    Acta Medica (Hradec Kralove); 2021; 64(1):1-7. PubMed ID: 33855952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid composition in serum cholesterol esters and phospholipids is linked to visceral and subcutaneous adipose tissue content in elderly individuals: a cross-sectional study.
    Rosqvist F; Bjermo H; Kullberg J; Johansson L; Michaëlsson K; Ahlström H; Lind L; Risérus U
    Lipids Health Dis; 2017 Apr; 16(1):68. PubMed ID: 28372558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease.
    Beals JW; Smith GI; Shankaran M; Fuchs A; Schweitzer GG; Yoshino J; Field T; Matthews M; Nyangau E; Morozov D; Mittendorfer B; Hellerstein MK; Klein S
    Hepatology; 2021 Sep; 74(3):1287-1299. PubMed ID: 33743554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual contributions of visceral fat and total body fat to subclinical atherosclerosis: The NEO study.
    Gast KB; den Heijer M; Smit JW; Widya RL; Lamb HJ; de Roos A; Jukema JW; Rosendaal FR; de Mutsert R;
    Atherosclerosis; 2015 Aug; 241(2):547-54. PubMed ID: 26100677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.
    Kim J; Lee H; Lim J; Oh J; Shin SS; Yoon M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.